Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Bradley, M. C.  [Clear All Filters]
Journal Article
J. E. Thistle, Petrick, J. L., Yang, B., Bradley, M. C., Graubard, B. I., and McGlynn, K. A., Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink, Cancer Epidemiol, vol. 55, pp. 170-175, 2018.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., Napolitano, G., and Murray, L. J., Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study, Br J Cancer, vol. 102, pp. 1415-21, 2010.
A. A. Florio, Graubard, B. I., Yang, B., Thistle, J. E., Bradley, M. C., McGlynn, K. A., and Petrick, J. L., Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink, Eur J Epidemiol, 2019.
M. C. Bradley, Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., and Hughes, C. M., Potentially inappropriate prescribing among older people in the United Kingdom, BMC Geriatr, vol. 14, p. 72, 2014.
M. C. Bradley, Murray, L. J., Cantwell, M. M., and Hughes, C. M., Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study, Br J Cancer, vol. 106, pp. 233-9, 2012.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., and Murray, L. J., Statins and pancreatic cancer risk: a nested case-control study, Cancer Causes Control, vol. 21, pp. 2093-100, 2010.
[Page last reviewed 4 October 2019]